Cognitive Complaints and Impairment Flashcards

1
Q

cognitive impairment can be

A

primary manifestation of disorder (altzheimer’s disease)

secondary manifestation and source of excess disability (delirium, medications, brain injury, HIV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

major DA tracts

A

nigostriatal (extra pyramidal motor)
mesolimic
mesocortical (cognition, emotion, substance abuse, psychosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

DA agonists

A

movement

depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DA antags

A

psychosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

where is NE synthesized

A

locus coreulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

where does LC project to

A

cortex
limbic
RAS
spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

adrenergic agents

A

depression
MAO-I
tricyclics
venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

adrenergic antagonists are for

A

tremor
anxiety
beta blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

setonergic agents used for

A

dpression

migraine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

5HT synthesized in

A

raphe nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

5HT project to

A
cortex
limbic system
striatum
cerebellum
blood vessels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ach synthesized in

A

basal forbrain (nucleus of basalis of Meynert)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ach projets to

A
olfactory bulb
hippocampus
amygdala
cortical association areas
==>ANS, NMJ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

anticholinergic agents

A

movement disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

cholinesterase inhibitors

A

Alteimers
organophosphates
nerve gases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GABA A binding sites for

A

benzos

barbiturates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

GABA B

A

baclofen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

three attentional networks

A

alerting
orientating
executive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

alerting brain

A

thalamic

R frontal and partietal activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Orienting brain

A

superior colliculus
frontal eye fields
temporoparietal
parietal activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

executive brain

A

anterior cingluate

DLPFC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

episodic memory

A

minutes to years
explicit
declarative
ex) short story, what you had for dinner last name, what you did on your last bday
–medial temporal lobes, anterior thalamic nucleus mammillary body, fornix, PFC

23
Q

semantic memory

A
minutes to years
explicit
declaritive
ex) knwing who the first president was
inferolateral temporal lobe
24
Q

procedural memory

A
minutes to years
explicit/implicit
nondeclaritive
ex) driving a car
basal ganglia cerebellum, supplementary motor area
25
working memory
seconds to minutes explicit declarative ex) phonological- phone number in your head before dialing-PFC, Broca's areas, wernicke ex) spatial- mentally following a route or rotating an object in your mind-PFC, visual-association areas
26
3 NT of arousal
cholinergic catecholaminergic glutamatergic
27
executive functions
volition/initiative planning purposeful action performance
28
dorsolateral PFC
executive function | working memory
29
lateral orbitofrontal
social intellifence
30
medial/ventral frontal lobe
apathy, amotivation
31
anterior cingulate
akinetic mutism | abulia
32
FDA approved medication in cognition treatment
none with altz and ADD being major expections
33
prominence of altz
11% in individuals >65 | 32-50% in individuals >85
34
Donepezil/Aricept lass
acetylcholinesterase inhibitor
35
adverse rxns donepezil
nausea/vomiting sinus brady 1st degree AV block
36
donepezil used for
altz
37
donepezil avaiable as
single daily dose
38
Memantine not recommended
alone
39
Galantamine is available as
extended-release capsule
40
rivastigmine is available as
patch
41
methylphenidate class
CNS stimulant
42
methylphenidate action
blocks reuptake of NE and DA | may also enhance release of catecholamines
43
methylphenidate adverse reactions
nervousness insomnia abuse potential
44
do not use methylphenidate with
MAOIs
45
methylphenidate may increase effects of
tricyclics | antiparkinsoniam agents
46
what frequently works when methylphenidate wont and what does it benefit in addition?
dextroamphetamine cognition, depression, anergia impaired motivation
47
Atomoxetine class
selective NE reuptake inhibitor
48
Atomoxetine action
inhibition of NE transporter
49
atmoxetine metbaolism
CYP2D6 (interactswith quinidine)
50
atomoxetine adverse reactions
liver toxicity | suicidal ideation
51
Amantadine and Memantine
- moderate-affinity uncompetitive NMDA receptor antagonists - dopamine agonists - increase DA release - decrease presyn DA reuptake - stimulate DA receptors - enhance post-syn dopamine R sensitity
52
neurotransmitter reuptake inhibitors
atomoxetine (strattera)-ADD | duloxetine (cymbalta)-antidepressant
53
Modafinil uses
excessive daytime somnolence in patients with narcolepsy | -may have a role in treatment of post-TBI fatigue and impairment
54
treatment of impaired cognition has two major forms
catecholaminergic agents | pro-cholinergic agents